REVIVEPEPTIDES
0

The class properties of short peptides as pharmacological agents, applied to this one

Published 26 October 2026 · REVIVE LAB UAE Research Desk · 5 min read
Peptides of ten to twenty residues are a well-understood class. They can bind targets with high affinity and specificity, they are made by solid-phase synthesis at modest cost, and they are degraded to amino acids with no toxic metabolites. Against that, they are cleared in minutes unless modified, they are destroyed in the gut and not absorbed intact, and most cannot cross cell membranes to reach intracellular targets. MOTS-c has every one of these class properties: easy to make and characterise, short-lived in plasma, inactive by mouth, and — because its proposed mechanism is intracellular and it has no receptor — dependent on an entry route that has not been shown.

The strengths

Synthesis of a 16-mer is routine and the product can be characterised completely by mass and chromatography, which is why the certificate for this pack is straightforward. Peptides rarely cause the idiosyncratic toxicity of small molecules because their breakdown products are natural. Where a receptor exists, as for GLP-1 or growth hormone-releasing hormone, a peptide can be exquisitely selective.

These are the reasons peptides are a growing drug class.

The limits

Oral delivery is defeated by stomach acid, pepsin, intestinal proteases and poor absorption across the gut wall; the few oral peptide drugs use elaborate formulations and achieve absorption of around one per cent. Plasma clearance is minutes. Cell entry is poor for anything above a few hundred daltons without a transporter or a cell-penetrating sequence. A peptide with an intracellular mechanism and no receptor therefore has an unexplained step between administration and effect.

BPC-157, by contrast, is stable in gastric juice, which is why its oral claims at least pass the first barrier.

Why it is here

Because these are the facts a reader needs to weigh any claim about any short peptide, and MOTS-c is one. It describes a class and no use of the pack.

MOTS-c is supplied by REVIVE LAB UAE for laboratory research use only, with identity by mass spectrometry and purity by HPLC for the batch. It is not for human or veterinary use, and no dosing, administration or protocol guidance is provided.

What it costs

FormatStrengthPriceAvailability
MOTS-c Pack40 mgAED 950In stock

Delivery is AED 40 flat and free on orders over AED 700. Payment is cash on delivery anywhere in the UAE, or USDT (TRC20) in advance, which takes 5% off the order total.

Frequently asked

The strengths?

Synthesis of a 16-mer is routine and the product can be characterised completely by mass and chromatography, which is why the certificate for this pack is straightforward. Peptides rarely cause the idiosyncratic toxicity of small molecules because their breakdown products are natural. Where a receptor exists, as for GLP-1 or growth hormone-releasing hormone, a peptide can be exquisitely selective.

Does REVIVE LAB UAE provide dosing guidance?

No. REVIVE LAB UAE supplies research materials and provides no dosing, administration or protocol guidance of any kind. Every product is sold for laboratory research use only and is not for human or veterinary consumption.

How fast is delivery in the UAE?

Stock is held in Dubai. An order confirmed before 4 PM Dubai time is dispatched the same working day, reaching Dubai and Abu Dhabi the same day and the remaining emirates within 24 hours. Delivery is AED 40 flat and free over AED 700.

MOTS-c Pack — in stock, dispatched from Dubai
HPLC-verified, lot certificate on every carton, 24-hour delivery nationwide. Browse the catalogue → All peptides UAE

Related reading

→ MOTS-c Pack — 40 mg → Plasma stability and protease clearance → BPC-157 stability in gastric juice

Supplied for laboratory research use only. Not for human or veterinary consumption. REVIVE LAB UAE provides no dosing, administration or protocol guidance.